Infertility Testing Market Size, Share, and Forecast by 2030
Infertility Testing Market: Strategic Insights
Infertility Testing Market
-
CAGR (2022 - 2030)8.6% -
Market Size 2022
US$ 424.20 Million -
Market Size 2030
US$ 820.08 Million
Market Dynamics
GROWTH DRIVERS
- Rising infertility rates
- Awareness of reproductive health
FUTURE TRENDS
- Hormonal and genetic testing advancements
- Home-based testing kits
OPPORTUNITIES
- Growth in fertility clinics
- Increased government support for fertility treatments
Key Players
- Merck KgaA
- Procter Gamble
- bioMerieux SA
- Alere Inc
- Babystart Ltd
- bioZhena Corporation
- Quidel Corporation
- CENTOGENE N V
- SCSA Diagnostics Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Male Infertility Testing and Female Infertility Testing
Test Kits
- Human Follicular Stimulating Hormone Test Kits
- Human Chorionic Gonadotropin Hormone Test Kits
- Luteinizing Hormone Test Kits
Sample
- Blood
- Urine
End User
- Hospitals & Clinics
- Fertility Centers
- Homecare